Bond AbbVie 1.2% ( US00287YAA73 ) in USD
| Issuer | AbbVie | ||||||
| Market price | 100.00 % ⇌ | ||||||
| Country | United States
|
||||||
| ISIN code |
US00287YAA73 ( in USD )
|
||||||
| Interest rate | 1.2% per year ( payment 2 times a year) | ||||||
| Maturity | 06/11/2015 - Bond has expired | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 3 500 000 000 USD | ||||||
| Cusip | 00287YAA7 | ||||||
| Standard & Poor's ( S&P ) rating | A ( Upper medium grade - Investment-grade ) | ||||||
| Moody's rating | Baa1 ( Lower medium grade - Investment-grade ) | ||||||
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YAA73, pays a coupon of 1.2% per year. The coupons are paid 2 times per year and the Bond maturity is 06/11/2015 The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YAA73, was rated Baa1 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YAA73, was rated A ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||
Français
Italiano
United States